EUS-guided FNA of proximal biliary strictures after negative ERCP brush cytology results

John DeWitt, Vijay Laxmi Misra, Julia Kim LeBlanc, Lee McHenry, Stuart Sherman

Research output: Contribution to journalArticle

141 Citations (Scopus)

Abstract

Background: Accurate nonoperative diagnosis of proximal biliary strictures (PBSs) is often difficult. Objective: To report our experience with EUS-guided FNA (EUS-FNA) of PBSs following negative or unsuccessful results with brush cytology during ERCP. Design: Retrospective cohort study. Setting: Single, tertiary referral hospital in Indianapolis, Indiana. Patients: Consecutive subjects from January 2001 to November 2004 who underwent EUS-FNA of a PBS documented by ERCP. Interventions: EUS-FNA of PBS. Main Outcome Measures: Performance of EUS-FNA, with the final diagnosis determined by surgical pathology study or the results of EUS-FNA and follow-up. Results: A total of 291 biliary strictures undergoing EUS were identified. Of these, 26 (9%) had PBSs and 2 were excluded. EUS-FNA was not attempted in 1 because no mass was visualized. The second had a PBS seen on magnetic resonance cholangiopancreatography, but no ERCP was performed. Twenty-four patients (14 men; mean age, 68 years) underwent EUS-FNA of a PBS following ERCP brush cytology studies that were either negative/nondiagnostic (20) or unable to be performed (4). EUS visualized a mass in 23 (96%) patients, including 13 in whom previous imaging detected no lesion. EUS-FNA (median, 4 passes; range, 1-11) demonstrated malignancy in 17 of 24 (71%) patients with findings showing adenocarcinoma (15), lymphoma (2), atypical cytology (3), or benign cells (4). No complications were noted. Pathology results from 8 of 24 (33%) patients who underwent surgery showed hilar cholangiocarcinoma (6), gallbladder cancer (1), and a benign, inflammatory stricture (1). The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of EUS-FNA were 77% (95% confidence interval [CI], 54%-92%), 100% (95% CI, 15%-100%), 100% (95% CI, 83%-100%), 29% (95% CI, 4%-71%), and 79% (95% CI, 58%-93%), respectively. Limitations: Histopathologic correlation of EUS-FNA findings was limited to 8 of 24 (33%) patients who underwent surgery. Conclusions: EUS-FNA is a sensitive method for the diagnosis of PBSs following negative results or unsuccessful ERCP brush cytology. The low negative predictive value does not permit reliable exclusion of malignancy following a negative biopsy.

Original languageEnglish
Pages (from-to)325-333
Number of pages9
JournalGastrointestinal Endoscopy
Volume64
Issue number3
DOIs
StatePublished - Sep 2006

Fingerprint

Endoscopic Ultrasound-Guided Fine Needle Aspiration
Endoscopic Retrograde Cholangiopancreatography
Cell Biology
Pathologic Constriction
Confidence Intervals
Klatskin Tumor
Magnetic Resonance Cholangiopancreatography
Gallbladder Neoplasms
Surgical Pathology
Tertiary Care Centers
Lymphoma
Neoplasms
Adenocarcinoma
Cohort Studies

ASJC Scopus subject areas

  • Gastroenterology

Cite this

EUS-guided FNA of proximal biliary strictures after negative ERCP brush cytology results. / DeWitt, John; Misra, Vijay Laxmi; LeBlanc, Julia Kim; McHenry, Lee; Sherman, Stuart.

In: Gastrointestinal Endoscopy, Vol. 64, No. 3, 09.2006, p. 325-333.

Research output: Contribution to journalArticle

@article{adc9e54fe3ce44d39cff61a7d988292c,
title = "EUS-guided FNA of proximal biliary strictures after negative ERCP brush cytology results",
abstract = "Background: Accurate nonoperative diagnosis of proximal biliary strictures (PBSs) is often difficult. Objective: To report our experience with EUS-guided FNA (EUS-FNA) of PBSs following negative or unsuccessful results with brush cytology during ERCP. Design: Retrospective cohort study. Setting: Single, tertiary referral hospital in Indianapolis, Indiana. Patients: Consecutive subjects from January 2001 to November 2004 who underwent EUS-FNA of a PBS documented by ERCP. Interventions: EUS-FNA of PBS. Main Outcome Measures: Performance of EUS-FNA, with the final diagnosis determined by surgical pathology study or the results of EUS-FNA and follow-up. Results: A total of 291 biliary strictures undergoing EUS were identified. Of these, 26 (9{\%}) had PBSs and 2 were excluded. EUS-FNA was not attempted in 1 because no mass was visualized. The second had a PBS seen on magnetic resonance cholangiopancreatography, but no ERCP was performed. Twenty-four patients (14 men; mean age, 68 years) underwent EUS-FNA of a PBS following ERCP brush cytology studies that were either negative/nondiagnostic (20) or unable to be performed (4). EUS visualized a mass in 23 (96{\%}) patients, including 13 in whom previous imaging detected no lesion. EUS-FNA (median, 4 passes; range, 1-11) demonstrated malignancy in 17 of 24 (71{\%}) patients with findings showing adenocarcinoma (15), lymphoma (2), atypical cytology (3), or benign cells (4). No complications were noted. Pathology results from 8 of 24 (33{\%}) patients who underwent surgery showed hilar cholangiocarcinoma (6), gallbladder cancer (1), and a benign, inflammatory stricture (1). The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of EUS-FNA were 77{\%} (95{\%} confidence interval [CI], 54{\%}-92{\%}), 100{\%} (95{\%} CI, 15{\%}-100{\%}), 100{\%} (95{\%} CI, 83{\%}-100{\%}), 29{\%} (95{\%} CI, 4{\%}-71{\%}), and 79{\%} (95{\%} CI, 58{\%}-93{\%}), respectively. Limitations: Histopathologic correlation of EUS-FNA findings was limited to 8 of 24 (33{\%}) patients who underwent surgery. Conclusions: EUS-FNA is a sensitive method for the diagnosis of PBSs following negative results or unsuccessful ERCP brush cytology. The low negative predictive value does not permit reliable exclusion of malignancy following a negative biopsy.",
author = "John DeWitt and Misra, {Vijay Laxmi} and LeBlanc, {Julia Kim} and Lee McHenry and Stuart Sherman",
year = "2006",
month = "9",
doi = "10.1016/j.gie.2005.11.064",
language = "English",
volume = "64",
pages = "325--333",
journal = "Gastrointestinal Endoscopy",
issn = "0016-5107",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - EUS-guided FNA of proximal biliary strictures after negative ERCP brush cytology results

AU - DeWitt, John

AU - Misra, Vijay Laxmi

AU - LeBlanc, Julia Kim

AU - McHenry, Lee

AU - Sherman, Stuart

PY - 2006/9

Y1 - 2006/9

N2 - Background: Accurate nonoperative diagnosis of proximal biliary strictures (PBSs) is often difficult. Objective: To report our experience with EUS-guided FNA (EUS-FNA) of PBSs following negative or unsuccessful results with brush cytology during ERCP. Design: Retrospective cohort study. Setting: Single, tertiary referral hospital in Indianapolis, Indiana. Patients: Consecutive subjects from January 2001 to November 2004 who underwent EUS-FNA of a PBS documented by ERCP. Interventions: EUS-FNA of PBS. Main Outcome Measures: Performance of EUS-FNA, with the final diagnosis determined by surgical pathology study or the results of EUS-FNA and follow-up. Results: A total of 291 biliary strictures undergoing EUS were identified. Of these, 26 (9%) had PBSs and 2 were excluded. EUS-FNA was not attempted in 1 because no mass was visualized. The second had a PBS seen on magnetic resonance cholangiopancreatography, but no ERCP was performed. Twenty-four patients (14 men; mean age, 68 years) underwent EUS-FNA of a PBS following ERCP brush cytology studies that were either negative/nondiagnostic (20) or unable to be performed (4). EUS visualized a mass in 23 (96%) patients, including 13 in whom previous imaging detected no lesion. EUS-FNA (median, 4 passes; range, 1-11) demonstrated malignancy in 17 of 24 (71%) patients with findings showing adenocarcinoma (15), lymphoma (2), atypical cytology (3), or benign cells (4). No complications were noted. Pathology results from 8 of 24 (33%) patients who underwent surgery showed hilar cholangiocarcinoma (6), gallbladder cancer (1), and a benign, inflammatory stricture (1). The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of EUS-FNA were 77% (95% confidence interval [CI], 54%-92%), 100% (95% CI, 15%-100%), 100% (95% CI, 83%-100%), 29% (95% CI, 4%-71%), and 79% (95% CI, 58%-93%), respectively. Limitations: Histopathologic correlation of EUS-FNA findings was limited to 8 of 24 (33%) patients who underwent surgery. Conclusions: EUS-FNA is a sensitive method for the diagnosis of PBSs following negative results or unsuccessful ERCP brush cytology. The low negative predictive value does not permit reliable exclusion of malignancy following a negative biopsy.

AB - Background: Accurate nonoperative diagnosis of proximal biliary strictures (PBSs) is often difficult. Objective: To report our experience with EUS-guided FNA (EUS-FNA) of PBSs following negative or unsuccessful results with brush cytology during ERCP. Design: Retrospective cohort study. Setting: Single, tertiary referral hospital in Indianapolis, Indiana. Patients: Consecutive subjects from January 2001 to November 2004 who underwent EUS-FNA of a PBS documented by ERCP. Interventions: EUS-FNA of PBS. Main Outcome Measures: Performance of EUS-FNA, with the final diagnosis determined by surgical pathology study or the results of EUS-FNA and follow-up. Results: A total of 291 biliary strictures undergoing EUS were identified. Of these, 26 (9%) had PBSs and 2 were excluded. EUS-FNA was not attempted in 1 because no mass was visualized. The second had a PBS seen on magnetic resonance cholangiopancreatography, but no ERCP was performed. Twenty-four patients (14 men; mean age, 68 years) underwent EUS-FNA of a PBS following ERCP brush cytology studies that were either negative/nondiagnostic (20) or unable to be performed (4). EUS visualized a mass in 23 (96%) patients, including 13 in whom previous imaging detected no lesion. EUS-FNA (median, 4 passes; range, 1-11) demonstrated malignancy in 17 of 24 (71%) patients with findings showing adenocarcinoma (15), lymphoma (2), atypical cytology (3), or benign cells (4). No complications were noted. Pathology results from 8 of 24 (33%) patients who underwent surgery showed hilar cholangiocarcinoma (6), gallbladder cancer (1), and a benign, inflammatory stricture (1). The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of EUS-FNA were 77% (95% confidence interval [CI], 54%-92%), 100% (95% CI, 15%-100%), 100% (95% CI, 83%-100%), 29% (95% CI, 4%-71%), and 79% (95% CI, 58%-93%), respectively. Limitations: Histopathologic correlation of EUS-FNA findings was limited to 8 of 24 (33%) patients who underwent surgery. Conclusions: EUS-FNA is a sensitive method for the diagnosis of PBSs following negative results or unsuccessful ERCP brush cytology. The low negative predictive value does not permit reliable exclusion of malignancy following a negative biopsy.

UR - http://www.scopus.com/inward/record.url?scp=33747178441&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747178441&partnerID=8YFLogxK

U2 - 10.1016/j.gie.2005.11.064

DO - 10.1016/j.gie.2005.11.064

M3 - Article

VL - 64

SP - 325

EP - 333

JO - Gastrointestinal Endoscopy

JF - Gastrointestinal Endoscopy

SN - 0016-5107

IS - 3

ER -